What Researchers Did
Researchers administered a single hyperbaric oxygen therapy (HBOT) program to 10 healthy male volunteers to investigate its effect on circulating metabolic stress biomarkers.
What They Found
They found that HBOT reduced serum concentrations of growth differentiation factor 15 and γ-glutamyltransferase, suggesting attenuated mitochondrial and oxidative stress. HBOT also increased adiponectin and decreased leptin levels, leading to an elevated adiponectin/leptin ratio, though triglyceride content increased.
What This Means for Canadian Patients
While preliminary, these findings suggest that HBOT could potentially help Canadian patients by reducing metabolic and oxidative stress, possibly offering a future therapeutic option for metabolic diseases. However, more research is needed before it can be considered for clinical use.
Canadian Relevance
This study does not have a direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
Limitations include the small sample size of 10 male volunteers, the pilot nature of the study, and the investigation of only a single HBOT program.